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Abstract: Discovering new materials to aid in the therapeutic delivery of drugs is in high demand.
PLGA, a FDA approved polymer, is well known in the literature to form films or nanoparticles that
can load, protect, and deliver drug molecules; however, its incompatibility with certain drugs (due to
hydrophilicity or charge repulsion interactions) limits its use. Combining PLGA or other polymers
such as polycaprolactone with other safe and positively-charged molecules, such as chitosan, has been
sought after to make hybrid systems that are more flexible in terms of loading ability, but often the
reactions for polymer coupling use harsh conditions, films, unpurified products, or create a single
unoptimized product. In this work, we aimed to investigate possible innovative improvements
regarding two synthetic procedures. Two methods were attempted and analytically compared using
nuclear magnetic resonance (NMR), fourier-transform infrared spectroscopy (FT-IR), and dynamic
scanning calorimetry (DSC) to furnish pure, homogenous, and tunable PLGA-chitosan hybrid
polymers. These were fully characterized by analytical methods. A series of hybrids was produced
that could be used to increase the suitability of PLGA with previously non-compatible drug molecules.
Keywords: PLGA; chitosan; hybrid polymers; chitosan-PLGA polymer; NMR; DSC; FT-IR
1. Introduction
The discovery of effective therapeutic drugs is becoming increasingly difficult as seen by the
drastic decline of new therapeutics accepted for public use each year. This is seen even with advances
in structure activity relationship (SAR) studies [1], computer simulations of target structures (specific
binding sequences and shape elucidation) [2], and high throughput screening methodology [3]. Novel
surfaces and delivery nanosystems have taken the spotlight as the leading hope to advance new drugs
from research into and beyond clinical studies by overcoming factors such as: lack of solubility, poor
stability, poor biodistribution, immune response activation, off-target affects, and poor accumulation at
the target site. Polymeric and lipid formulations have been taken advantage of to create fine-tuned
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systems to include targeting [4–6], triggerable activation (heat, light, reactive oxygen species (ROS),
pH) [7–9], and varied uptake mechanisms to deliver pharmaceutics against numerous diseases [10–12].
In this respect, poly(lactic-co-glycolic acid) (PLGA) is of high interest due to the fact that it
is: (1) FDA approved; (2) chemico-physically tunable to match biodistribution or loading needs;
(3) capable of producing both nanosystems or polymeric scaffolds; (4) chemically modifiable to include
stealthing moieties (polyethylene glycol, PEG) and/or targeting ligands. All of these aspects have been
widely exploited in production of PLGA nanoparticles (NPs) for the possible cure of a plethora of
diseases [13–18].
While PLGA NPs display many advantages in drug formulation, in comparison with cationic
bio/polymers, they can suffer poor encapsulation efficiency when loading negatively-charged molecules.
For example, while cationic bio/polymers (i.e., chitosan, cationic lipids, poly-ethylenimine, etc.) [19] can
ionically bind negatively-charged DNA and form polyplexes, repulsion between the negatively-charged
gene material and PLGA leads to negligible loading efficiencies. In this view, production of a co-polymer
including chemical features needed for controlled release, absence of charge repulsion, and stable
loading within the protective hybrid polymer assembly could be the correct answer to these limitations.
Previously, attempts to overcome these limitations were investigated in various ways. First,
by surface engineering negatively-charged NPs (such as PLGA) with cationic molecules in order to
allow DNA absorption onto the surface [20–23]. While this approach could improve theoretical loading
of gene material or other positively-charged molecules onto polymeric NPs, the stability of the exposed
drugs in a biological environment and control of their release are still lacking. Secondly, a synthesis of
chitosan on a PLGA film for adsorption of hydrophilic molecules of chitosan for protein loading [24].
While in this study loading was improved, the reaction was only monitored based on time and the film
remained intact throughout all analysis and the presence of absorbed but not reacted chitosan could
be present. By creating a controlled synthesis of hybrid polymers, it would be possible to include
improved encapsulation of drugs into PLGA assemblies, improving encapsulation of the molecule as
well as protecting it within the structure from desorption in the blood and degradation. Furthermore,
systematically synthesizing series of hybrid polymers could allow for tunability to include controlled
release kinetics and degradation kinetics of the molecules as well.
Therefore, in this research we attempt two different synthetic methods to create a pure hybrid
PLGA-chitosan polymer series: solid phase synthesis on a film (adapted from Li et al. [24]), or in
solution chemical reaction (adopted from a reaction to react chitosan to polycaprolactone [25]). This will
allow for the synthesize of a unique series of PLGA-chitosan hybrid polymers with tailored and tunable
physico-chemical characteristics that could be used to expand the use of PLGA delivery systems of
currently incompatible drugs or environments and in a variety of drug delivery assemblies to treat a
larger range of disease states.
2. Materials and Methods
2.1. Materials
Poly (d,l-lactide-co-glycolide) acid [PLGA RG-503H 50:50, inherent viscosity in 0.1% (w/v)
chloroform (CHCl3) at 25 ◦C = 0.38 dLg−1] was used as received from the manufacturer
(Boehringer-Ingelheim, Ingelheim am Rhein, Germany). According to the experimental titration
results of the carboxylic end of the polymers (4.94 mg potassium hydroxide (KOH)/g polymer) the
molecular weight of RG-503H was calculated to be 11,000 Da. Low Molecular Weight chitosan,
(mw 14,000) was purchased from Sigma Aldrich (Sigma Aldrich, Milano, Italy). All the solvents were
of analytical grade, and all other chemicals and media were used as received from the manufacturers,
and unless otherwise indicated, obtained from Sigma-Aldrich (Sigma Aldrich, Milano, Italy).
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2.2. Solid Phase Synthesis of PLGA-Chitosan Co-Polymer
The solid phase reaction of PLGA and chitosan was performed following the method of Ai.D.
Li et al. with minor modifications (Scheme 1) [24]. Briefly, a PLGA solution (50 mg) was weighed
into a round bottom flask and solubilized in 5 mL dicloromethane (DCM) and dried by rotary
evaporation to create a thin film. The film was then washed for 1 h with 5 mL 6 w/v% NaOH (sodium
hydroxide). This solution was discarded and the film was gently washed three times with 10 mL
dilute HCl (hydrochloric acid 10%) followed by three more times with distilled water. The film was
then completely covered in a solution containing N-Hydroxysuccinimide (NHS, 10 mgmL−1) and
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 10 mgmL−1) and reacted for another 6 h at
room temperature in order to activate the acid group of PLGA with the NHS ester to promote the amide
coupling with the amine of chitosan. This solution was discarded and the film was ultimately covered
by a solution of 80 mL (reaction in round bottom flask) chitosan of 25 mgmL−1 (pH 3.5). Remarkably,
to achieve this pH value in which the chitosan becomes more soluble with decreasing pH it becomes
highly viscous, HCl (1N) was added dropwise and stirred vigorously for several minutes between
each additional drop. Therefore, rigorous stirring for several minutes is needed in order to ensure the
added HCl is dispersed uniformly throughout the solution and to avoid pockets of extreme acidity.
After reacting for 48 h, the chitosan solution became much more transparent and less dense. The same
procedure up to this point was also performed on a film on the surface of a glass petri dish (diameter
10 cm) with the following changes: the PLGA (150 mg) in 9 mL DCM evenly dispersed over the surface
of the petri dish was left to evaporate at room temperature under a chemical hood overnight instead
of on a rotary evaporator. The volumes required to cover the film with ~1 cm of each solution were
decreased: NaOH 15 mL, EDC 15 mL (10 mgmL−1), NHS (15 mL 15 mL (10 mgmL−1), chitosan 15 mL
(25 mgmL−1, pH 3.5). This decrease in volume was possible because unlike in the round bottom flask
where a large volume is needed to fill in the 3D spherical space, on a flat surface the volume needed
to cover the film is a much smaller cylindrical cross-section of the round bottom flask (1 cm thick
cylinder). All material from the round bottom or petri dish was poured into a separation funnel and
the reaction vessel was washed 3 × with water followed by 3 × with DCM (10 mL each), in order to
remove products and starting material that are soluble in aqueous or organic solvents, and added to
the separatory funnel. After allowing the extraction to separate for 1 h at room temperature in the
separation funnel, three distinct layers formed during separation: a clear DCM layer, a middle white
emulsion, and the yellow chitosan solution. The three layers were separated into separate containers
and lyophilized to calculate a percent yield and further characterization.
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Scheme 1. Solid phase reacti f LGA film with chitosan.
2.3. Characterization Protocols of PLGA-Chitosan o- oly er in Solid-Phase.
Characterization of chitosan-PLGA co-polymer was achieved by analysi i R. The
FT-IR spectra were recorded by a Vertex 70 (Bruker Optics, Ettlingen, Germany) FT-IR spectrophotometer,
equipped with a deuterium triglycine sulphate (DTGS) detector (Bruker Optics, Ettlingen, Germany).
Setting parameters are: resolution 4 cm−1; apodization weak. The spectral range was 4000–600 cm−1
with 32 scans for each spectrum. The ATR spectra were recorded using the Golden-Gate accessory
(Golden Gate™ Single Reflection Diamond ATR Series MkII).
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1H NMR and 13C samples of the solid phase reactions were run on a Bruker 600 mHz NMR (Bruker,
Milano, Italy). Simply, 4 mg of sample were dissolved in deuterated water with 1% v/v deuterated acetic
acid added (Chitosan, 700 uL), or deuterated dimethylsulfoxide (DMSO) (PLGA-chitosan product,
700 uL), scanned 40 (1H) or 3000 (13C) times and analyzed by Bruker Top Spin software (Bruker,
Milano, Italy).
2.4. Reaction of Chitosan and PLGA in Solution
To perform the conjugation between chitosan and PLGA in organic solution, an organic soluble
SDS-chitosan salt was formed (Scheme 2). In particular, adapting a protocol published by Cai et al. [25],
a solution of chitosan (200 mg) in 2% v/v) acetic acid was precipitated with SDS (Sodium dodecyl
sulfate 560 mg) in a rapport of 1:100 for 2 h. The reaction was centrifuged for 10 min at 10,000 rpm in an
ALC PK121 multispeed centrifuge (Concordia, Modena, Italy), the supernatant was discarded, and the
precipitate was dried in a desiccator under negative pressure overnight. Simultaneously, PLGA was
activated for reaction with chitosan by means of NHS-DDC technology. The covalent binding between
the carboxy terminus of the polymer PLGA RG503H and the terminal amine of the peptide has been
formed by standard methods, namely the activation of the carboxy group of PLGA by means of an
ester with N-hydroxysuccinimide in the presence of dicyclohexylcarbodiimide, and the subsequent
formation of an amidic linkage with the N-terminus of the unprotected peptide. Thus, to a solution
of PLGA RG503H (1.00 g, 88 µmol) in anhydrous dioxane (5 mL), DCC (dicyclohexylcarbodiimide.
19.0 mg, 93 µmol) and N-hydroxysuccinimide (NHS, 11.0 mg, 93 µmol) were added, and the mixture
was stirred for 4 h at 20 ◦C. After, the dicyclohexylurea was filtered away and the solution was decanted
into cold anhydrous diethyl ether. The insoluble polymer was collected and purified by dissolution in
DCM, followed by precipitation by the addition of anhydrous diethyl ether, then dried under reduced
pressure. The content of NHS groups reacted with PLGA RG503H was determined by 1H-NMR
spectroscopy (DPX 200; Bruker, Rheinstetten, Germany) in DMSO-d6, from the relative peak area of
the multiplet at 2.95 ppm and of the multiplet at 1.80–1.60 ppm, corresponding to the protons of the
N-succinimide and those of the methyl groups of the polymer, respectively, and resulted to be 49 µmol
NHS/g of polymer. After having obtained both polymers, a fixed amount (50 mg) of the chitosan
salt was then solubilized in anhydrous dimethylformamide (DMF, 10 mL) and reacted with different
amounts (10, 50, or 240 mg) of activated PLGA-NHS (corresponding to ratio 1:5, 1:1, 5:1 chitosan:
PLGA, respectively) and reacted for 48 h.
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All the products were purified and isolated by means of centrifugation at 12,000 rpm for
10 min to remove any precipitated material during the reaction. The supernatant was then dried by
rotoevaporation to yield a white/yellow powder containing the PLGA-chitosan/SDS salt conjugate.
The SDS was then removed from the conjugate, which led to a precipitation of the final product by
incubation in 50 mL 15% TRIS pH 8.0 for 48 h. The precipitate was then centrifuged at 12,000 rpm with
an ALC PK121 multispeed centrifuge and the supernatant was decanted away. The final product was
then dried by lyophilization and stored in a desiccator at room temperature until analysis. Solubility of
the samples was tested by weighing 1 mg of each product and testing its ability to dissolve in DMSO
or acetic acid (2% v/v) of concentrations of 200 ugmL−1.
2.5. Characterization Protocols of PLGA-Chitosan Co-Polymer in Solution
FTIR was described as previously described. The FT-IR spectra were recorded by a Vertex 70
(Bruker Optics, Ettlingen, Germany) FT-IR spectrophotometer, equipped with a deuterium triglycine
sulphate (DTGS) detector. Setting parameters are: resolution 4 cm−1; apodization weak. The spectral
range was 4000–600 cm−1 with 32 scans for each spectrum. The ATR spectra were recorded using the
Golden-Gate accessory (Golden Gate™ Single Reflection Diamond ATR Series MkII).
After purification, NMR spectra were acquired at 300 K using an AVANCE III HD 600 Bruker
spectrometer, equipped with a 2.5 mm H/X CPMAS probe operating at 600.13 and 150.90 MHz for 1H
and 13C, respectively (Bruker, Milano, Italy). Samples were packed into 2.5 mm zirconia rotors and
spun at the magic angle. 13C NMR spectra were obtained using a standard pulse sequence for cross
polarization (CP), at 16 kHz magic angle spinning (MAS) rate. The relevant acquisition parameters for
CP-MAS 13C NMR spectra were: 45 kHz spectral width, 10 s relaxation delay, 2.5 µs 1H 90◦ pulse,
62.5 kHz radio frequency field strength for Hartmann−Hahn match, 2k data points, and 2k scans.
All chemical shifts were referenced by adjusting the spectrometer field to the value corresponding to
38.48 ppm chemical shift for the deshielded line of the adamantane 13C NMR spectrum.
Dynamic scanning Calorimetry of DSC was performed on a Netzsch Phox DSC 200 PC using
the Netzsch Proteus analysis software (NETZSCH-Gerätebau GmbH, Selb, Germany). Samples were
precisely weighed between 2–4 mg each into NETZSCH DSC-crucibles (Al; 25 uL) and sealed with
their appropriate lids. An empty crucible was used as the reference sample. Samples were analyzed
with the following thermometric gradient: 2 min isothermal gradient to standardize the starting point
at 15 ◦C, 15–320 ◦C over 38 min increasing at 10 ◦C per minute, with a 2 min isothermal section.
3. Results
The most direct method of conjugating PLGA and chitosan is an amid bond formation between
the amine on chitosan and the carboxylic acid of PLGA (Scheme 1). Functionally however, this reaction
is complicated due to the extreme difference in solubility between the two molecules. Previous
attempts reacted chitosan in solution with a PLGA film to create a positively-charged surface aiming
to create nanofibers without the need for purification [24]. Another researcher produced the hybrid
PLGA-chitosan polymer for the creation of nanoparticles, but it required harsh conditions (concentrated
nitric acid) [26]. Therefore, to create a pure, reproducible, and controllable hybrid polymer that could
be used in solution for NP formation, a reaction was performed under milder conditions on a PLGA
film created by evaporating PLGA on a surface activating it with EDC and NHS and reacting it with a
large excess of chitosan. After 48 h, the chitosan solution was removed and the product was purified
in a biphasic solution of 0.1% acetic acid (PLGA-chitosan product) and DCM (non-reacted PLGA).
Initial reactions were performed in a round bottom flask; however, to make the reaction greener by
decreasing the ratio of surface area:volume (to decrease amount of solvent and reactants needed to
cover the PLGA film), reactions were performed in a flat petri dish. This simple change not only
decreased reaction volume (80 mL to 10 mL), but it also increased the % yield from ~25% to 50%.
Characterization of the product was performed by FTIR spectroscopy (a common technique for
investigating interactions between polymers) and NMR. General FTIR points of interest for the reaction
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arise in the broad band between 3450 and 3200 cm−1 (νOH + νNH) and two weak peaks at 2940 cm−1
and 2890 cm−1 (νCH2) (Figure S1, top panel). More critical for the identification of the conjugation
of PLGA to chitosan are the major characteristic absorption bands at around 1648 and 1588 cm−1,
corresponding to amide I (νC=O) and amide II (δNH + νCN) of the residual N-acetyl groups. Under
the band centered at 1585 cm−1, the contribution of δNH2 is also hidden, which overlaps the amide II
peak [27]. Pure PLGA exhibits the strong characteristic adsorption peaks at 1170 and 1090 cm−1 (νCOC,
ether), 1130 cm−1 (ρCH3), 1452, 1390, and 745 cm−1 (δCH), and peaks 3020 and 2930 cm−1, which were
attributed to νCH2 from glycolic acid portion, and νCH3 from the lactic acid portion. The most notable
peak to discern the presence of PLGA arises at 1749 cm−1 (νC=O, ester) (Figure S1, bottom panel) [28].
FTIR analysis of the product showed that the mild acetic acid conditions did not result in the covalent
linkage between PLGA and chitosan (Figure 1). While a shift in the amid bonds at 1648 and 1588 cm−1
were observed, the new peaks did not correspond to further amid bond creation, but instead showed
the resemblance of the formation of a chitosan salt [29] with bands further downfield at 1627 and
1517 cm−1. Also, only a small emergence of a peak indicating the presence of the C=O of PLGA at
1748 cm−1, but instead a peak at 1703 cm−1 indicating the appearance of an acid was observed.
1 
 
 
 
Figure 1. FT-IR/ATR spectra of unmodified poly lactic-co-glycolic acid (red), unmodified chitosan
(blue), and PLGA-chitosan product (green).
NMR analysis confirms the poor reaction results. 1H NMR of the product and the chitosan control
show little to no difference with the H2 peak at 3 ppm and the H3-6 peaks as a broad series of peaks
at 3.5–4 ppm. These peaks corresponded to the literature precedence of the 13C NMR peaks of the
main carbon ring at ~C1 (100 ppm), C3-5 (73–85 ppm), and C2,6 (55–60 ppm). However, the normal
peaks expected for the PLGA C=O (170 ppm) or CH3 (1.5 ppm and 15 ppm 13C) or its degradation
products (glycolic and lactic acid) are not present (Figure 2). Only small fragment peaks that do not
cross correlate upon 2D analysis (Figure S2). Degradation of the PLGA into small fragments during
the reaction would explain the FTIR results showing the formation of a small acid peak. It also could
explain the amid bond shifts to that of the salt formation as small negatively-charged acidic degradation
products could lead to a salt formation with the free amine of chitosan.
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While th reaction of PLGA and chitosa d in the literature, it is often performed with
harsh conditions on gels or without purificati . sing a solid phas reaction with mild reaction
conditions did not prove successful. This ruled out this method as a viable option to create a controlled
series of hybrid polymer variants for further characterization; therefore, more stable and controllable
methodology was pursued.
The mild reaction conditions led to a lack of product formation. To overcome this, an alternate
method was adapted in which chitosan is precipitated as an SDS salt in order to improve its solubility
in organic solutions (DMSO, choloroform, and DMF) [25].
This intermediate was then conjugated to PLGA-NHS in anhydrous DMF. To test the flexibility of
the reaction, and to analyze the physical characteristics of various PLGA-chitosan hybrid polymers,
a series of three reactions was performed: (1) an excess of chitosan in a 5:1 molar ration, (2) 1:1
chitosan: PLGA and (3) 1 chitosan: 5 PLGA (Table 1). The latter corresponds to an average of one PLGA
being available for each sugar unit of chitosan. After reacting activated PLGA with chitosan-SDS for
48 h, the salt was dissociated in Tris 15% pH 8 for 48 h. The percent yield of the reactions increased
proportionally with the increasing rapport of PLGA: chitosan in the reaction as shown in Table I (55%,
75%, and 82%). The solubility of the products also suggested an increased PLGA attachment due to
the decreasing solubility in 2% acetic acid (v/v).
Table 1. Solution phase reaction conditions of PLGA and Chitosan-SDS.
Reaction Chitosan-SDS(mg Chitosan)
PLGA-NHS
(mg) Recovery (%)
PLGA:Chitosan in
Initial Reaction
Solution (mol)
Solubility in
Acetic Acid a
1 50 10 55 1:5 soluble
2 50 50 75 1:1 semi soluble
3 50 240 82 5:1 Not soluble
a. 200 ug/mL 2% v/v.
The conjugation of PLGA to chitosan again was analyzed by FTIR, and 13C NMR in solid state (due
to the differences in solubility between the products). The PLGA and chitosan starting materials were
identical to as described previously (Figure 1, Figure S1). In a PLGA concentration dependent manner,
the progressive appearance and intensification of the band at 1755 cm−1, indicating the presence
of PLGA (ester C=O stretching), can be observed (Figure 3). Unlike the solid-state reaction, bands
indicating a chitosan salt formation were not observed (including the presence of the chitosan-SDS salt
formation (1624 and 1523 cm−1)) (Figure S3). Instead, there was a clear and concentration dependent
(based on initial PLGA amounts), shift indicating amid bond formation (Figure 3). This was confirmed
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by observing the amide I and II peaks (1650 and 1585 cm−1) shift to 1633 cm−1 (amide I) and 1548 cm−1
(amide II) (Figure 3). As compared with pure chitosan, the δNH contribution of the primary amine
for the band at 1580 cm−1 decreases or even disappears, because of a change of primary amine in
the chitosan chain into amide groups, as already attested in the literature [30]. The displacement of
the band from 1586 cm−1 (chitosan) to 1549 cm−1 (PLGA-chitosan) suggests that the grafting reaction
occurred mainly by the reaction between the −NH2 chitosan groups and −COOH PLGA groups.
Furthermore, the band at 3184 cm−1 progressively increases, associated with NH stretching of the
secondary amide (Figure 3 inset).
1 
 
 
 
Figure 3. FTIR scan of PLGA-chitosan hybrid products of the reactions synthesized with different
molar rapport of PLGA:chitosan of reaction (1) 1:5. black (2) 1:1. blue (3) 5:1. green, and (4) pure
chitosan (red inset).
NMR analysis was used to support the FTIR findings (Figure 4). The solid-state NMR of pure
chitosan showed the characteristic broad singlet at 100 ppm (carbon 1) along with two broad multiplet
peaks between 50 pp, (carbon 2–5) and 90 ppm (carbon 6) in accordance with literature precedence
(Figure 4 purple box) [31]. The pure PLGA exhibits the CH and CH2 peaks at 70 and 60 ppm, respectively,
as well as the CH3 peak at 15 ppm and C=O peak at 170 ppm (Figure 4, orange boxes). In all reactions,
the iconic peaks of the chitosan can be seen. In all three reactions, the PLGA peak corresponding to the
CH2 is hidden under the chitosan (purple box) and residual TRIS salt (blue box) peaks from 50–75 ppm,
but the emergence of the CH peak at 70 ppm is observed (Figure 4, Figure S4). More evident however;
is that by increasing the initial amount of PLGA in the reaction, the peak corresponding to C=O at
170 ppm (indicated by a star) as well as that of the CH3 group (indicated by an @) are seen to directly
increase in intensity (Figure 4 orange boxes). It is important to note that SDS, and Chitosan-SDS salt
(peaks 20–40 ppm) are not present in any of the samples indicating full removal of the salt back to the
original chitosan structure in the product (Figure S4, red box). NMR analysis showed constant and
equal NMR spectra across multiple product samples indicating the homogeneity and controllability of
each product.
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Figure 4. Solid state 13C NMR analysis with hig lighted peaks of interest: chitosan (purple), PLGA
(orange), TRIS salt (blue). Numbers indicate the Carbons (C1-6) of the chitosan ring structure or their
respective hydrogens as depicted in the structure (Top left), * indicates the c rbon of the PLGA carbonyl
peak, and @ indic ting the PLGA methyl group.
To further validate the conjugation f PLGA to chitosan, DSC analysis was performed (Figure 5).
The transitional pe k of PLGA was seen at 50 ◦C along with an e dothermic transition during its
degradation between 280–380 ◦C. The chitosan control shows the liberation of the water entrapped
between the chitosan chains at 115 ◦C along with an exothermic transition at pproximately 300 ◦C
reasoned to be the d gradation f the c itosan ring structures permitting 3-D rotation. Analysis of the
polymer sa ple showed a shift in all transitional states dependent on th concentra ion of PLGA in the
initial reaction solution. With increasing amounts of PLGA, the transitional phase at 50 ◦C disappeared
due to the loss of the glass tran ition when bou d t chitosan. I a phys cal mixture of PLGA and
chitosan however this transition was still observed (Figure S5). Secon ly, a shift to higher temperatures
of the wat r loss from 120 ◦C to 150 ◦C in sample 3 (with the most PLGA) exhibiting numerou peaks
in this range. The nergy required to remove the water associated with the chitosan chains is incr ased
by the incre sed encumbrance of PLGA. Finally, th disappearance of the tra sition p ak at around
290 ◦C caused by the bulky PLGA sterically hindering the free rotation of the chitosan chains as well as
cancellation of the endothermic (PLGA) and exoth rmic (Chitosan) energies were observed supporting
the FTIR d NMR data of the presence f increasing amounts of PLGA chemically linked to the
chitosan chain. To ensure these changes w re n t caused by the presence of the chitosan-sds salt,
a sampl was also analyzed s owing none of the charact ristics of the po mer products (Figure S5).
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t ree series of analysi not only demonstra e the formation of the hybrid polymer series using
m ld reaction conditions, but al o show the versatility of the reaction in its bility to be stoichiometric
controlled to crea e a unif rm prod ct unlike that seen by t e olid-state reaction. Th formation
of the chitosan-SDS made it optimal for the reaction in organic solvents with PLGA. By varying the
r tion of PLGA i the reactio conditions from a 1:5 excess of chitosan, t 1:1, and finally to 5:1 excess
of PLGA, it was possible to create a variation of hybrid polymers. The hybrid series wa not only
verified by the analytical chara teriz tions, bu also y the difference of solubility of the pr duct.
Controlling the reaction in a stoich ometric ontrolled ma ner to cre te such clean and reproducible
product, hybrid polymers greatly inc eases he translatability d fe s ble uses of these polymers in
drug delivery purposes.
. isc ssi cl si s
i i e aterials t sta ilize lec les it or sta ility, s l ilit , r i c ati ilit
r erties is ecessar t c ti e a a ci e isease treat e t et s it “critical” t
-c ati le r s. PLGA offers a er r isi ase aterial as it is a r e a as
ee se extensively to specifically target drugs to diseases as NPs or as site specific delivery agents
inserted as a film but is limited in loa i g positively-charged molecules.
re ti e co-polymers in a constant and controlled manner offers an increasing utility of PLGA
assemblies for a broader range of potential drug candidates in which it is currently non-compatible.
T this end, two reaction meth ds were attempted to conjugat negatively-charged PLGA to the
positively-charged chitos n to form a series of nov l co-polym rs. Previous works have attempted
to make chitosan hybrid polymers using harsh reaction conditions (nitric acid), PLGA films, or in
solution (to make polycaprolactone hybrid p lymers) in a non- urified and unco trollable manner.
To truly benefit from these types of hybrid polymers, th reaction must be r producible, co trollabl ,
create a seri s of pure homogenous products that can be selected dependent on the therap utic ne .
Data indicated that solid-phase synthesis using a PLGA film and mild reaction conditions
was insufficient to cre te PLGA-chitosan hybrid polymers, but instead le to a salt f rmati ith
degradation products in solution. However, by utilizing an SDS salting out reaction to create a chitosan
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SDS intermediate that is soluble in organic solvents, a series of PLGA-chitosan co-polymers with
different molar ratios were produced.
Remarkably, this reaction was able to furnish a unique series of pure and reproducible
PLGA-chitosan hybrids with various molar rapport and solubilities. This controlled synthesis
method makes these hybrids prime candidates for protection and delivery of a wide range of previously
non-combatable drugs either as NPs formed through chitosan self-assembly techniques (for those
still soluble in acidic solutions) or for the encapsulation in stable and non-toxic films for long-term
controlled release (for those insoluble in biological solutions).
These preliminary results could pave the way to further advances in the application of PLGA-based
nanotherapeutics, expanding the tunability of the core polymer structure to be better suited for a wider
range of drugs candidates to be loaded, protected, and delivered to diseased cells improving their
potency and efficacy.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4360/12/4/823/s1,
Figure S1: Full FTIR Scan of PLGA and chitosan polymers, Figure S2: 2D NMR correlation analysis of the 1H
and 13C PLGA-chitosan reaction product, Figure S3: FTIR analysis of chitosan control (Red), chitosan-SDS salt
(green) and SDS salt (blue), Figure S4: Solid state 13C NMR analysis with highlighted peaks of interest: chitosan
(purple), SDS (red), TRIS salt (blue), Figure S5: Dynamic scanning calorimetry analysis: chitosan-SDS salt (black
line), chitosan: PLGA 1:1.5 physical mixture (green line).
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